To investigate the role of ACSL3 in the progression of NAFLD to HCC, we assessed cell morphology and ACSL3 antigenicity in human NAFLD-related HCC tissues, ranging from mild to severe. This evidence concerns the gene ACSL3 and metabolic dysfunction-associated steatotic liver disease.